NCT03943576已完成1 期
Adipose-Derived Stem Cells (ADSCs) Injections for Knee Osteoarthritis
适应症
干预措施
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 25
- 试验地点
- 1
- 主要终点
- WOMAC pain score
研究概览
简要总结
The aim of the investigators study was to investigate the safety and efficacy of allogeneic ADSCs for the clinical treatment of knee osteoarthritis.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Single (Participant)
入排标准
- 年龄范围
- 40 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Provision of signed and dated informed consent form
- •Aged 40 to 80 years old (inclusive)
- •Kellgren-Lawrence grading II-IV, as determined by American College ofRheumatology (ACR) criteria for osteoarthritis of the knee
- •Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain score of 7 ~ 17 (inclusive) in the target knee despite use of NSAID
- •Contraindicated to long term systemic NSAID (e.g. suffer from severe gastrointestinal side effects upon systemic NSAID administration, or due to underlying increased gastrointestinal, cardiovascular, or renal risk) and not able to receive or wish to delay knee arthroplasty
排除标准
- •With previous surgery of articular fracture, ligament reconstruction, meniscal reconstruction, and knee arthroplasty on the target knee joint
- •With previous intra-articular intervention (e.g. steroid, anesthetics, hyaluronate, arthroscopic surgery) on the target knee joint 12 weeks prior to screening
- •Administered or required systemic or local on the target knee joint immunosuppressive agent, anti-inflammatory drug, steroid, analgesics, opioid, or duloxetine for OA knee except for acetaminophen and NSAID within 1 week prior to screening
- •With joint diseases other than knee osteoarthritis considered by investigator not eligible to enter the study
- •Unable to receive MRI examination, including allergic to the contrast medium for MRI used in the study, with known history of claustrophobia, having any existing metallic intraocular foreign body or active/inactive implanted medical devices, such as cardiac pacemaker, cochlear, intracranial vascular clips or neurostimulator
- •Active or suspected infection of the target knee joint
- •History of human immunodeficiency virus (HIV) infection
- •History of malignancy within 2 years prior to screening
- •With body mass index (BMI) greater or equal to 35 kg/m2
- •Known hypersensitivity to any component of the investigational product or the active control
- •Participated other investigational study within 4 weeks prior to screening
- •With ongoing or within the past 2 years serious medical conditions (e.g. concomitant illness) such as cardiovascular (e.g. New York Heart Association grade III or IV), hepatic (e.g. Child-Pugh Class C), psychiatric condition (e.g. alcoholism, drug abuse), medical history, physical findings, or laboratory abnormality that in the investigators' opinion could interfere with the results of the trial or adversely affect the safety of the subject
- •Female subject with childbearing potential who is lactating or has positive serum or urine pregnancy test at Screening
- •Subject with childbearing potential refuses to use highly effective contraceptives from signing informed consent until Final/Early Termination Visit. At least two forms of birth control must be adopted and one of which must be a barrier method. Acceptable forms include:
- •Established use of oral, injected or implanted hormonal methods of contraception
- •Placement of an intrauterine device (IUD) or intrauterine system (IUS)
- •Barrier methods of contraception: condom, or occlusive cap (diaphragmor cervical/vault caps)
研究组 & 干预措施
GXCPC1
Experimental
GXCPC1 contains 6.7×10^6 or 4×10^7 allogeneic adipose-derived stem cells (ADSCs) in 3 mL
干预措施: GXCPC1 (Drug)
hyaluronic acid
Active Comparator
Hya Joint Plus synovial fluid supplement 3mL
干预措施: HA (Device)
结局指标
主要结局
WOMAC pain score
时间窗: week 24
Change from baseline in WOMAC pain score at Week 24
次要结局
- MRI(week 0, 24, 48)
- Visual Analogue Scale (VAS)(week 0, 1, 4, 12, 24)
- 12-item Short Form (SF-12)(week 0, 1, 4, 12, 24)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
1 期
Clinical Trial Study About Human Adipose-Derived Stem Cells in the Liver CirrhosisLiver CirrhosisNCT02297867Gwo Xi Stem Cell Applied Technology Co., Ltd.6
招募中
2 期
A Phase II Open-label Single-arm Study to Evaluate the Efficacy and Safety of ADSCs in Subjects With Liver CirrhosisLiver CirrhosisNCT04088058Gwo Xi Stem Cell Applied Technology Co., Ltd.20
已完成
1 期
Clinical Trial Study About Human Adipose-Derived Stem Cells in the StrokeStrokeNCT02813512Gwo Xi Stem Cell Applied Technology Co., Ltd.3
已完成
1 期
ADSC Injections for Pain Management of Osteoarthritis in the Human Knee JointOsteoarthritis of the KneeNCT02357485Fodor, Peter B, M.D.6
Unknown
不适用
The Clinical Application of Adipose-Derived Stem Cells on Facial RejuvenationFaciesNCT02923219Xuzhou Medical University50